Eris Lifesciences Limited has announced a Board Meeting scheduled for Wednesday, July 29, 2026. The primary agenda will be to consider and approve the standalone and consolidated unaudited financial results for the quarter ended June 30, 2026. The company also reminded stakeholders that the trading window, closed since July 1, 2026, will remain shut until 48 hours after the financial results declaration.
Board Meeting Announcement
Eris Lifesciences Limited has formally announced that a meeting of its Board of Directors is scheduled to convene on Wednesday, July 29, 2026. The key purpose of this meeting is to review and approve the company’s financial performance for the first quarter of the fiscal year 2027, which ended on June 30, 2026. The board will consider both the standalone and consolidated unaudited financial results.
Trading Window Update
In line with prior communication, the trading window for the company’s securities, which was initially closed from July 1, 2026, will continue to remain closed. This closure will extend for a period of 48 hours following the official declaration of the financial results. This measure is in accordance with the SEBI [Prohibition of Insider Trading] Regulations, 2015, and the company’s internal ‘Code of Conduct’ designed to regulate trading activities by designated persons and their immediate relatives.
Source: BSE
